Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Xue Chen; Xiuping Han; Bo Cheng; Hui Li; Lingling Liu; Songmei Geng; Linfeng Li; Jie Li; Qing Guo; Guoyi Zhang; Hong Fang; Jianzhong Zhang

doi:10.1097/CM9.0000000000003071

Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Xue Chen
, Xiuping Han
, Bo Cheng
, Hui Li
, Lingling Liu
, Songmei Geng
, Linfeng Li
, Jie Li
, Qing Guo
, Guoyi Zhang
, Hong Fang
, Jianzhong Zhang

Peking University
China Medical University
Fujian Medical University
First Affiliated Hospital of Chongqing Medical University
The Second Affiliated Hospital of Xi'an Jiaotong University
Capital Medical University
Central South University
Sun Yat-Sen University
Chinese Academy of Medical Sciences
Zhejiang University

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	1480-1482
Number of pages	3
Journal	Chinese Medical Journal
Volume	137
Issue number	12
DOIs	https://doi.org/10.1097/CM9.0000000000003071
State	Published - 20 Jun 2024
Externally published	Yes

Access to Document

10.1097/CM9.0000000000003071

Cite this

Chen, X., Han, X., Cheng, B., Li, H., Liu, L., Geng, S., Li, L., Li, J., Guo, Q., Zhang, G., Fang, H., & Zhang, J. (2024). Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial. Chinese Medical Journal, 137(12), 1480-1482. https://doi.org/10.1097/CM9.0000000000003071

@article{f6f65e6531fa4835a56120e887ddfe5b,

title = "Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial",

author = "Xue Chen and Xiuping Han and Bo Cheng and Hui Li and Lingling Liu and Songmei Geng and Linfeng Li and Jie Li and Qing Guo and Guoyi Zhang and Hong Fang and Jianzhong Zhang",

year = "2024",

month = jun,

day = "20",

doi = "10.1097/CM9.0000000000003071",

language = "英语",

volume = "137",

pages = "1480--1482",

journal = "Chinese Medical Journal",

issn = "0366-6999",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

Chen, X, Han, X, Cheng, B, Li, H, Liu, L, Geng, S, Li, L, Li, J, Guo, Q, Zhang, G, Fang, H & Zhang, J 2024, 'Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial', Chinese Medical Journal, vol. 137, no. 12, pp. 1480-1482. https://doi.org/10.1097/CM9.0000000000003071

Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial. / Chen, Xue; Han, Xiuping; Cheng, Bo et al.
In: Chinese Medical Journal, Vol. 137, No. 12, 20.06.2024, p. 1480-1482.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria

T2 - A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

AU - Chen, Xue

AU - Han, Xiuping

AU - Cheng, Bo

AU - Li, Hui

AU - Liu, Lingling

AU - Geng, Songmei

AU - Li, Linfeng

AU - Li, Jie

AU - Guo, Qing

AU - Zhang, Guoyi

AU - Fang, Hong

AU - Zhang, Jianzhong

PY - 2024/6/20

Y1 - 2024/6/20

UR - https://www.scopus.com/pages/publications/85196767016

U2 - 10.1097/CM9.0000000000003071

DO - 10.1097/CM9.0000000000003071

M3 - 快报

C2 - 38557589

AN - SCOPUS:85196767016

SN - 0366-6999

VL - 137

SP - 1480

EP - 1482

JO - Chinese Medical Journal

JF - Chinese Medical Journal

IS - 12

ER -

Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Access to Document

Other files and links

Cite this